The latest data, presented at VIVA and The VEINS

Physicians and researchers present groundbreaking findings from late-breaking clinical trials, follow-up data from major randomized trials and registries, and first-in-man experiences with novel devices or drugs. Each presentation is followed by a discussion and Q&A with a panel of expert faculty.

Important 2024 Dates

  • June 6 - Abstract submission portal opens
  • August 8 - Abstract submission deadline
  • Week of August 26 - Abstracts selected for VIVA and The VEINS 2024, decision notifications sent
  • September 23 - Final presentations due for LBCT sessions

Embargo Policy

VIVA and The VEINS embargo Late-Breaking Clinical Trial information from becoming public until after the commencement of the session as listed in the conference program or on No publication, exhibitor, or affiliated company may disseminate information until after the commencement of the Late-Breaking Clinical Trial session in which it is presented.

Review Process

Abstracts will be evaluated and scored based on the following criteria:

  • Interest to field
  • Research methods
  • Quality of data
  • Primary endpoint presented

Accepted late-breaking clinical trials will be presented:

  • Sunday, November 3 (The VEINS)
  • Monday, November 4 (VIVA)
  • Tuesday, November 5 (VIVA)

The review committee may determine that your abstract may be more appropriate for a different session or conference than you originally submitted.

If you have questions please contact Brita Thorne via e-mail: